Skip to main content

Advertisement

SpringerLink
Log in

Attacking the flank: targeting new pathways in SBMA

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Androgen withdrawal–based therapeutic strategies for spinal and bulbar muscular atrophy (SBMA) have shown limited benefit in clinical trials, and therapies for this disease still remain a considerable challenge. The finding that a class of migraine medications, the triptans, improve disease in a mouse model of SBMA suggests a new route for future investigations into SBMA therapies (pages 1531–1538).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Targeting CGRP1 upregulation in SBMA using naratriptan.

References

  1. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Nature 352, 77–79 (1991).

    Article  CAS  Google Scholar 

  2. Kennedy, W.R., Alter, M. & Sung, J.H. Neurology 18, 671–680 (1968).

    Article  CAS  Google Scholar 

  3. Sobue, G. et al. Brain 112, 209–232 (1989).

    Article  Google Scholar 

  4. Chevalier-Larsen, E.S. et al. J. Neurosci. 24, 4778–4786 (2004).

    Article  CAS  Google Scholar 

  5. Katsuno, M. et al. Neuron 35, 843–854 (2002).

    Article  CAS  Google Scholar 

  6. Takeyama, K. et al. Neuron 35, 855–864 (2002).

    Article  CAS  Google Scholar 

  7. Fernández-Rhodes, L.E. et al. Lancet Neurol. 10, 140–147 (2011).

    Article  Google Scholar 

  8. Katsuno, M. et al. Lancet Neurol. 9, 875–884 (2010).

    Article  CAS  Google Scholar 

  9. Rhodes, L.E. et al. Brain 132, 3242–3251 (2009).

    Article  Google Scholar 

  10. Montie, H.L. et al. Hum. Mol. Genet. 18, 1937–1950 (2009).

    Article  CAS  Google Scholar 

  11. Nedelsky, N.B. et al. Neuron 67, 936–952 (2010).

    Article  CAS  Google Scholar 

  12. Orr, C.R. et al. J. Biol. Chem. 285, 35567–35577 (2010).

    Article  CAS  Google Scholar 

  13. Minamiyama, M. et al. Nat. Med. 18, 1531–1538 (2012).

    Article  CAS  Google Scholar 

  14. Ho, T.W., Edvinsson, L. & Goadsby, P.J. Nat. Rev. Neurol. 6, 573–582 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diane E. Merry is in the Department of Biochemistry and Molecular Biology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.,

    Diane E Merry

Authors
  1. Diane E Merry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Diane E Merry.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merry, D. Attacking the flank: targeting new pathways in SBMA. Nat Med 18, 1461–1463 (2012). https://doi.org/10.1038/nm.2967

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2967

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation